Cargando…
Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty
BACKGROUND: The empirical use of tranexamic acid (TXA) for bleeding remains controversial because of the distinct fibrinolytic phenotypes observed after injury. This study sought to assess the efficacy of postoperative TXA in patients presenting with different fibrinolytic phenotypes after total kne...
Autores principales: | Liu, Jiacheng, Wang, Han, Wu, Xiangdong, Lei, Yiting, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800271/ https://www.ncbi.nlm.nih.gov/pubmed/35093142 http://dx.doi.org/10.1186/s13018-022-02958-0 |
Ejemplares similares
-
Total Hip Arthroplasty Patients with Distinct Postoperative Fibrinolytic Phenotypes Require Different Antifibrinolytic Strategies
por: Liu, Jiacheng, et al.
Publicado: (2022) -
Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: A meta-analysis
por: Ma, Qi-ming, et al.
Publicado: (2020) -
Tranexamic Acid in Civilian Trauma Care in the California Prehospital Antifibrinolytic Therapy Study
por: Neeki, Michael M., et al.
Publicado: (2018) -
Commentary: Epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolytics
por: Faraoni, David
Publicado: (2020) -
Safety and Efficacy of Tranexamic Acid in Total Knee Arthroplasty
por: Yu, Xiao, et al.
Publicado: (2015)